Predictors of long-term mortality after hospitalization for acute exacerbation of COPD

Tuberculosis and Respiratory Diseases

Volumn 60, Issue 2, 2006, Pages 205-214

  Jung, Hae Sun ^a   Lee, Jin Hwa ^a   Chun, Eun Mi ^a   Moon, Jin Wook ^a   Chang, Jung Hyun ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

COPD; Heart rate; Mortality determinants; Right ventricular systolic pressure

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART RATE; HEART RIGHT VENTRICLE PRESSURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PLEURA THICKENING; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SCAR FORMATION; SURVIVAL TIME; THORAX RADIOGRAPHY;

EID: 33646574952     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2006.60.2.205     Document Type: Article

References (30)

1. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002;121(Suppl):121S-6S.
2. Yun SH. Acute exacerbation of chronic obstructive pulmonary disease. Korean J Crit Care Med 2003; 18:1-6.
3. Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003;163:1180-6.
4. Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, et al. Mortality after hospitalization for COPD. Chest 2002;121:1441-8.
5. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14-20.
6. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease: the SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996;154:959-67.
7. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003;124:459-67.
8. Hansen EF, Phanareth K, Laursen LC, Kok-Jensen A, Dirksen A. Reversible and irreversible airflow obstruction as predictors of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1267-71.
9. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study. Am Rev Respir Dis 1979; 119:895-902.
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACH II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
11. Ai-Ping C, Lee KH, Lim TK. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest 2005;128:518-24.
12. Goel A, Pinckney RG, Littenberg B. APACHE II predicts long-term survival in COPD patients admitted to a general medical ward. J Gen Intern Med 2003;18:824-30.
13. Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest 2001;119:1840-9.
14. Fuso L, Incalzi RA, Pistelli R, Muzzolon R, Valente S, Pagliari G, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995;98:272-7.
15. American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD [Internet]. Version 1.2. New York: American Thoracic Society; 2004 [updated 2005 September 8]. Available from: http://www.thoracic.org/copd/.
16. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163: 1256-76.
17. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
18. Feigenbaum H, Armstrong WF, Ryan T. Feigenbaum's echocardiography. 6th ed. London: Lippincott Williams & Wilkins;2005.
19. Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995;274:1852-7.
20. Dallari R, Barozzi G, Pinelli G, Meright V, Grandi P, Manzotti M, et al. Predictors of survival in subjects with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Respiration 1994;61: 8-13.
21. Skwarski K, MacNee W, Wraith PK, Silwinski P, Zielinski J. Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Chest 1991;100:1522-7.
22. Wuertemberger G, Zielinsky J, Sliwinsky P, Auw-Haedrich C, Matthys H. Survival in chronic obstructive pulmonary disease after diagnosis of pulmonary hypertension related to long-term oxygen therapy. Lung 1990;168:762-9.
23. Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, Badier M, et al. Left atrial and ventricular filling in chronic obstructive pulmonary disease: an echocardiography and doppler study. Am J Respir Crit Care Med 2000;162:670-5.
24. Lacasse M, Maltais F, Poirier P, Lacasse Y, Marquis K, Jobin J, et al. Post-exercise heart rate recovery and mortality in chronic obstructive pulmonary disease. Respir Med 2005;99:877-86.
25. Burrows B, Earle RH. Prediction of survival in patients with chronic airway obstruction. Am Rev Respir Dis 1969;99:865-71.
26. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61.
27. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
28. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003;123:1460-6.
29. Fuld JP, Kilduff LP, Neder JA, Pitsiladis Y, Lean ME, Ward SA, et al. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2005;60:531-7.
30. Schols AM, Wesseling G, Kester AD, de Vries G, Mostert R, Slangen J, et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J 2001;17:33 7-42.